Clinical Trial Detail

NCT ID NCT01573702
Title Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Erlotinib

Age Groups: adult

No variant requirements are available.